Cathie Wood started to build up the position in Takeda Pharmaceutical Co in Q3 2020 and continued to invest until Q1 2021. Since then they sold 18.7 Million shares. The investor completely sold their stake between Q2 2021 and Q1 2022.
Avg closing price
Price range
Sold -7.86 Million shares
Q1 2022
Avg closing price
$14.68
Price range
$13.54
-
$15.35
Sold 41.8% shares (-5.64 Million shares)
Q4 2021
Avg closing price
$14.03
Price range
$13.17
-
$16.40
Sold 12.9% shares (-1.99 Million shares)
Q3 2021
Avg closing price
$16.79
Price range
$16.30
-
$17.26
Sold 17.2% shares (-3.22 Million shares)
Q2 2021
Avg closing price
$17.02
Price range
$16.55
-
$18.64
Increased shares by 117.2% (+10.1 Million shares)
Q1 2021
Avg closing price
$17.99
Price range
$16.71
-
$19.90
Increased shares by 645.3% (+7.46 Million shares)
Q4 2020